The downregulation of VEGFR2 and P42/P44 MAPK signaling by methylated EGCG, which inhibits the growth of hepatocellular carcinoma cells and the formation of blood vessels in the tumor microenvironment, has been implicated in this effect [134]. This evidence concerns the gene KDR and hepatocellular carcinoma.